• ''Cannibalistic'' phagocytosis in acute megakaryoblastic leukemia with NUP98::KDM5A fusion
• <em>BCR</em>-<em>ABL1</em> co-occurring with <em>CBFA2T3</em>-<em>GLIS2</em> and RAM immunophenotype in a non-Down syndrome infant with acute megakaryoblastic leukemia
• <em>CBFA2T3::GLIS2</em>-positive acute leukemia with RAM and mixed T/megakaryocytic phenotype
• "TAM"ing of the shrew-challenges in the diagnosis of Neonatal leukemia with Down's syndrome -A case report with literature review
• A case of acute megakaryoblastic leukaemia following a mediastinal germ cell tumour
• A rare case of acute megakaryoblastic leukaemia with constitutional ring chromosome 21
• A rare case of acute megakaryoblastic leukemia with t(11;17)(q23;q21) and KMT2A::MLLT6 fusion
• A rare case of transformation from relapsed acute monocytic leukaemia with KMT2A::MLLT10 to acute megakaryoblastic leukaemia
• A retrospective analysis of gene fusions and treatment outcomes in pediatric acute megakaryoblastic leukemia without Down syndrome
• Activation of NOTCH signaling impedes cell proliferation and survival in acute megakaryoblastic leukemia
• Acute megakaryoblastic leukaemia shows high frequency of chromosome 1q aberrations and dismal outcome
• Acute megakaryoblastic leukemia associated with Sotos syndrome: A case report and review of evolving genetic associations
• Acute megakaryoblastic leukemia in a pediatric patient
• Acute megakaryoblastic leukemia mimicking a disseminated tumor
• Acute megakaryoblastic leukemia with trisomy 3 and CBFA2T3::GLIS2: A case report
• Acute Megakaryocytic Leukemia arising from Megakaryocyte/Erythroid Progenitor (MEP)-like cell
• Acute monocytic leukemia with KMT2A::LASP1 developed 9 months after diagnosis of acute megakaryoblastic leukemia in a 2-year-old boy
• Acute panmylelosis with myelofibrosis - A rare case report with review of literature
• Acute promyelocytic leukemia with FIP1L1::RARA fusion gene: The clinical utility of transcriptome sequencing and bioinformatic analyses
• Adult acute megakaryoblastic leukemia with persistent diarrhea and extreme thrombocytosis: A very unusual case
• Advances in molecular characterization of myeloid proliferations associated with Down syndrome
• Advances in molecular characterization of pediatric acute megakaryoblastic leukemia not associated with Down syndrome; impact on therapy development
• Analysis 33 patients of non-DS-AMKL with or without acquired trisomy 21 from multiple centers and compared to 118 AML patients
• Apoptosis of Megakaryocytic Leukemia Cell Line Meg-01 Induced by TSP-1 Via CD36/Caspase-3
• Are Induced Pluripotent Stem Cells a Step towards Modeling Pediatric Leukemias?
• BCR-ABL1 co-occurring with CBFA2T3-GLIS2 and RAM immunophenotype in a non-Down syndrome infant with acute megakaryoblastic leukemia
• Blocking PAK1 kinase activity promotes the differentiation of acute megakaryocytic leukemia cells and induces their apoptosis
• c-Mpl-del, a c-Mpl alternative splicing isoform, promotes AMKL progression and chemoresistance
• Case Report: The Value of Genomic Analysis in a Case of Megakaryoblastic Leukemia With Atypical Initial Manifestation
• CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target
• CBFA2T3-GLIS2 model of pediatric acute megakaryoblastic leukemia identifies FOLR1 as a CAR T cell target
• CBFA2T3-GLIS2-dependent pediatric acute megakaryoblastic leukemia is driven by GLIS2 and sensitive to navitoclax
• CBFA2T3::GLIS2 pediatric acute megakaryoblastic leukemia is sensitive to BCL-XL inhibition by navitoclax and DT2216
• CBFA2T3::GLIS2-positive acute leukemia with RAM and mixed T/megakaryocytic phenotype
• CD34 and CD117 negative pure erythroid leukemia and phenotypic differences with acute megakaryoblastic leukemia
• Clinical Analysis of Pediatric Acute Megakaryocytic Leukemia With CBFA2T3-GLIS2 Fusion Gene
• Clonal Myeloproliferative Disorders in Patients with Down Syndrome-Treatment and Outcome Results from an Institution in Argentina
• Cryptic KMT2A/MLLT10 fusion detected by next-generation sequencing in a case of pediatric acute megakaryoblastic leukemia
• Design and preclinical testing of an anti-CD41 CAR T cell for the treatment of acute megakaryoblastic leukaemia
• Dissecting stepwise mutational impairment of megakaryopoiesis in a model of Down syndrome-associated leukemia
• Down syndrome and leukemia: An insight into the disease biology and current treatment options
• Down syndrome-associated leukaemias: current evidence and challenges
• Erythroid/megakaryocytic differentiation confers BCL-XL dependency and venetoclax resistance in acute myeloid leukemia
• Fasudil promotes polyploidization of megakaryoblasts in an acute megakaryocyte leukemia model
• Frequent detection of <em>CBFA2T3::GLIS2</em> fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression
• Frequent detection of CBFA2T3::GLIS2 fusion and RAM-phenotype in pediatric non-Down syndrome acute megakaryoblastic leukemia: a possible novel relationship with aberrant cytoplasmic CD3 expression
• GATA1: function through disorder
• Gene mutation landscape of a rare patient with acute megakaryoblastic leukemia after treatment of intracranial germ cell tumor
• Generation of 2 isogenic clones from a patient with Trisomy 21 and a GATA1 mutation
• Generation of CHOPi-008-B, a euploid iPSC line from a patient with Trisomy 21 and a GATA1 mutation
• Germline GATA1s-generating mutations predispose to leukemia with acquired trisomy 21 and Down syndrome-like phenotype
• Haematopoietic cell transplantation for children with acute megakaryoblastic leukaemia without Down syndrome
• Hematological neoplasia associated with primary mediastinal germ-cell tumor treated with hematopoietic stem cell transplantation
• High <em>EVI1</em> Expression Predicts Adverse Outcomes in Children With <em>De Novo</em> Acute Myeloid Leukemia
• High EVI1 Expression Predicts Adverse Outcomes in Children With De Novo Acute Myeloid Leukemia
• Immunophenotypic Analysis of Acute Megakaryoblastic Leukemia: A EuroFlow Study
• Immunophenotypic markers for the evaluation of minimal/measurable residual disease in acute megakaryoblastic leukemia
• Infant Acute Leukemia
• Infant Leukemia
• Is it primary myelofibrosis or chronic megakaryocytic leukemia?
• JAK: Not Just Another Kinase
• Landscape of driver mutations and their clinical effects on Down syndrome-related myeloid neoplasms
• Lineage switch in a pediatric patient with KMT2A-MLLT3 from acute megakaryoblastic leukemia to T cell acute lymphoblastic leukemia at the fourth relapse after allo-HSCT: with literature review
• Long-term follow-up of haploidentical haematopoietic stem cell transplantation in paediatric patients with high-risk acute myeloid leukaemia: Report from a single centre
• Megakaryocytic emperipolesis in a therapy-related acute-mixed phenotypic leukemia
• Mixed-phenotype acute leukemia, T/megakaryoblastic: does it really exist?
• Myeloblasts transition to megakaryoblastic immunophenotypes over time in some patients with myelodysplastic syndromes
• Myeloid Leukemia of Down Syndrome
• Myeloid sarcoma with RBM15::MRTFA (MKL1) mimicking vascular neoplasm
• NKL Homeobox Genes NKX2-3 and NKX2-4 Deregulate Megakaryocytic-Erythroid Cell Differentiation in AML
• Pathologic, cytogenetic, and molecular features of acute myeloid leukemia with megakaryocytic differentiation: A report from the Children's Oncology Group
• Pediatric Non-Down Syndrome Acute Megakaryoblastic Leukemia With Unusual Immunophenotype
• Pediatric non-Down's syndrome acute megakaryoblastic leukemia patients in China: A single center's real-world analysis
• Post PARP inhibitor therapy-related acute megakaryoblastic leukemia in a patient with germline <em>BRCA1</em>-mutated high-grade serous ovarian carcinoma
• Post PARP inhibitor therapy-related acute megakaryoblastic leukemia in a patient with germline BRCA1-mutated high-grade serous ovarian carcinoma
• Revealing the intratumoral heterogeneity of non-DS acute megakaryoblastic leukemia in single-cell resolution
• Screening of ETO2-GLIS2-induced Super Enhancers identifies targetable cooperative dependencies in acute megakaryoblastic leukemia
• Second Hematologic Malignancies Associated With Primary Mediastinal Germ Cell Tumors: A Population-based Study
• Sensitive detection of GATA1 mutations using complementary DNA-based analysis for transient abnormal myelopoiesis associated with the Down syndrome
• Skin Manifestations of Micafungin Breakthrough Disseminated Trichosporonosis in Acute Megakaryoblastic Leukemia
• Stepwise GATA1 and SMC3 mutations alter megakaryocyte differentiation in a Down syndrome leukemia model
• Structure-function analysis of the role of megakaryoblastic leukemia 1 in megakaryocyte polyploidization
• Survival outcomes of myeloid leukemia associated with Down syndrome and de novo acute myeloid leukemia in children: Experience from a single tertiary center in Thailand
• Survival Outcomes of Patients With Primary Mediastinal Germ Cell Tumors: A Retrospective Single-institutional Experience
• Synchronous Development of Acute Megakaryoblastic Leukaemia and Disseminated Melanoma following Treatment of a Germ Cell Tumour: A Case Report
• Synergistic roles of DYRK1A and GATA1 in trisomy 21 megakaryopoiesis
• t(1;7;22)(p13;q21;q13) is a novel 3-way variant of t(1;22)(p13;q13) neonatal acute megakaryoblastic leukemia: A case report
• Targeting cyclin-dependent kinases 4/6 inhibits survival of megakaryoblasts in acute megakaryoblastic leukaemia
• The abundance of the short GATA1 isoform affects megakaryocyte differentiation and leukemic predisposition in mice
• The diagnostic profile of rare acute myelomegakaryoblastic leukemia
• The hematopoietic microenvironment of the fetal liver and transient abnormal myelopoiesis associated with Down syndrome: A review
• The Hematopoietic TALE-Code Shows Normal Activity of IRX1 in Myeloid Progenitors and Reveals Ectopic Expression of IRX3 and IRX5 in Acute Myeloid Leukemia
• The megakaryocytic transcription factor ARID3A suppresses leukemia pathogenesis
• The Mutational Landscape of Myeloid Leukaemia in Down Syndrome
• Therapy-related acute megakaryoblastic leukemia with severe myelofibrosis
• Ultrastructural alterations of megakaryocytes in thrombocytopenia: A review of 43 cases
• Unifying heterogeneous expression data to predict targets for CAR-T cell therapy
• Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric <em>de novo</em> acute megakaryoblastic leukemia without Down syndrome in China: A single-center study
• Unmanipulated haploidentical hematopoietic stem cell transplantation for pediatric de novo acute megakaryoblastic leukemia without Down syndrome in China: A single-center study
• Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia-related changes with megakaryoblastic differentiation